News

Hosted on MSN23d
TD Cowen maintains Boston Scientific buy rating, $110 target
The evidence from this trial is expected to bolster Boston Scientific's efforts to promote the concomitant use of Watchman. The analyst's comments reflect confidence in the potential market impact ...
Investor's Business Daily on MSN8d
IBD Stock Of The Day, Boston Scientific, A 'Top Decile' Player, Is Eyeing Two Entries
Boston Scientific is Thursday's IBD Stock Of The Day. Shares are forming a double-bottom base, while approaching an early ...